Mirum Pharmaceuticals, Inc. · NASDAQ:MIRM
Bjerkholt Eric sold 5,000 Mirum Pharmaceuticals, Inc. shares (Form 4)
Traded Jul 6, 2026 · Filed Jul 8, 2026
On Jul 6, 2026, Bjerkholt Eric (CHIEF FINANCIAL OFFICER) sold 5,000 Mirum Pharmaceuticals, Inc. shares at an average US$122.25 for US$611K under a trading plan, leaving 42,181 shares. Filed Jul 8, 2026 (Form 4).
- Sold
- 5,000 shares
- Price
- US$122.25 average (US$121.67 to US$124.94)
- Value
- US$611K
- Holding after
- 42,181 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Common Stock | Sale | 3,124 | US$121.67 | 44,057 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 1,048 | US$122.43 | 43,009 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 528 | US$123.84 | 42,481 | Direct |
| Jul 6, 2026 | Common Stock | Sale | 300 | US$124.94 | 42,181 | Direct |
Source
Related
- Mirum Pharmaceuticals, Inc.
- Bjerkholt Eric
- Mirum Pharmaceuticals, Inc. shareholders
- Form 4 · Bjerkholt Eric · Sep 15, 2026
- Form 4 · Bjerkholt Eric · Aug 12, 2026
- Form 4 · Bjerkholt Eric · Jun 9, 2026
- Form 4 · Howe Jolanda · Oct 19, 2026
- Form 4 · Peetz Christopher · Oct 6, 2026
- Form 4 · Howe Jolanda · Sep 3, 2026
- Form 4 · Peetz Christopher · Sep 3, 2026
- Form 4 · Howe Jolanda · Aug 19, 2026